Edition:
India

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

47.34USD
1:30am IST
Change (% chg)

$1.21 (+2.62%)
Prev Close
$46.13
Open
$46.11
Day's High
$47.39
Day's Low
$45.20
Volume
537,558
Avg. Vol
526,922
52-wk High
$73.72
52-wk Low
$19.55

Latest Key Developments (Source: Significant Developments)

Arrowhead Pharmaceuticals Qtrly Earnings Per Share $0.21
Tuesday, 6 Aug 2019 

Aug 5 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2019 THIRD QUARTER RESULTS.ARROWHEAD PHARMACEUTICALS INC QTRLY EARNINGS PER SHARE $0.21.ARROWHEAD PHARMACEUTICALS INC QTRLY REVENUE $42.7 MILLION VERSUS $727,375.  Full Article

Arrowhead Pharmaceuticals Receives Orphan Drug Designation For ARO-ANG3
Wednesday, 17 Jul 2019 

July 16 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS RECEIVES ORPHAN DRUG DESIGNATION FOR ARO-ANG3.ARROWHEAD PHARMACEUTICALS - FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO ARO-ANG3 FOR TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA.  Full Article

Arrowhead Pharmaceuticals Reports Qtrly Earnings Per Share $0.24
Thursday, 9 May 2019 

May 8 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2019 SECOND QUARTER RESULTS.QTRLY EARNINGS PER SHARE $0.24.QTRLY REVENUE$48.2 MILLION VERSUS $650,125.Q2 EARNINGS PER SHARE VIEW $0.19, REVENUE VIEW $43.0 MILLION -- REFINITIV IBES DATA.  Full Article

Arrowhead Pharmaceuticals Earns $25 Million Milestone Payment From Janssen
Wednesday, 24 Apr 2019 

April 24 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD BEGINS TRIPLE COMBINATION COHORT IN CHRONIC HBV PATIENTS AND EARNS $25 MILLION MILESTONE PAYMENT FROM JANSSEN.ARROWHEAD - BEGUN DOSING IN NEW TRIPLE COMBINATION COHORT THAT INCLUDES JNJ-3989 AND ADDITIONAL UNDISCLOSED AGENTS SELECTED BY JANSSEN PHARMACEUTICALS.ARROWHEAD - ELIGIBLE TO RECEIVE REMAINING $25 MILLION UPON INITIATION OF A PHASE 2 STUDY BY JANSSEN.  Full Article

Arrowhead Pharmaceuticals Inc Quarterly Loss Per Share $0.12
Wednesday, 12 Dec 2018 

Dec 11 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS INC QUARTERLY LOSS PER SHARE $0.12.ARROWHEAD PHARMACEUTICALS INC QUARTERLY REVENUES $11.26 MILLION VERSUS $8.7 MILLION.  Full Article

Arrowhead Pharmaceuticals Inc Files For Offering Of Up To 3.3 Mln Shares Of Common Stock
Friday, 30 Nov 2018 

Nov 29 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS INC FILES FOR OFFERING OF UP TO 3.3 MILLION SHARES OF COMMON STOCK - SEC FILING.  Full Article

Arrowhead Pharmaceuticals Quarterly Net Loss Per Share $0.18
Wednesday, 8 Aug 2018 

Aug 7 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2018 THIRD QUARTER RESULTS.ARROWHEAD PHARMACEUTICALS INC QUARTERLY NET LOSS PER SHARE $0.18.ARROWHEAD PHARMACEUTICALS INC QUARTERLY REVENUE $727,375 VERSUS $9.34 MILLION.  Full Article

Arrowhead Pharmaceuticals Earns $10 Mln Milestone Payment From Amgen
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS SAYS EARNED $10 MILLION MILESTONE PAYMENT FROM AMGEN FOLLOWING ADMINISTRATION OF FIRST DOSE OF AMG 890.  Full Article